Featured Image Alt Text: Retatrutide peptide clinical evidence map showing GIP, GLP-1, glucagon receptor activity, safety, and investigational status Suggested Schema: Article schema only INFOGRAPHIC BRIEFS Infographic Brief 1 Placement: How Does Retatrutide Peptide Work

Red Flags in Before and After Photos Different lighting: Bathroom fluorescent light vs golden-hour window light can make anyone's skin look dramatically different regardless of what product was used Different camera distance or angle: Even a few inches closer creates apparent texture smoothing "Results in 1 week": Anyone showing dramatic wrinkle reversal in one week is using either injectable delivery, a film-forming agent for temporary tightening, or misleading photography No defined timeframe: Legitimate results specify exactly how many weeks of use are shown No single variable: If the person changed multiple products during the documented period, you cannot attribute results to GHK-Cu specifically Green Flags in Credible Documentation Identical lighting in both photos (same room, same time of day, same source) 3D imaging or VISIA documentation the gold standard used in clinical studies Specified timeline with consistent single-product use Progressive documentation (4-week, 8-week, 12-week) rather than a single dramatic comparison Honest acknowledgment that results vary and are gradual The clinical studies that produced GHK-Cu's most impressive numbers 55.8% wrinkle volume reduction used VISIA 3D profilometry imaging systems that eliminate all lighting and angle variables entirely

What Is AltRx GLP-1
Youll receive clear recommendations, expected outcomes, and transparent pricing
People on any type of weight loss medication lost an average of 8.3kg during treatment, but regained 4.8kg within the first year and were back to their original weight within 1.7 years of stopping the drugs
Our detailed tirzepatide reconstitution chart covers every common vial size with recommended water volumes